Sri Trang Gloves (Thailand) Valuation

Q: What is the Fair Price of STG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

STG (SGD0.4) is trading above our estimate of [[fair value]] (SGD0.12)

Is STG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of STG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: STG (SGD0.4) is trading above our estimate of fair value (SGD0.12)

Significantly Below Fair Value: STG is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for STG?

Key metric: As STG is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for STG. This is calculated by dividing STG's market cap by their current earnings.
What is STG's PE Ratio?
PE Ratio	78.1x
Earnings	฿396.37m
Market Cap	฿30.94b

STG key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.4x
Enterprise Value/EBITDA	13.1x
PEG Ratio	1.6x

Price to Earnings Ratio vs Peers

How does STG's PE Ratio compare to its peers?

The above table shows the PE ratio for STG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	36.4x
AP4 Riverstone Holdings	17.9x	9.8%	S$1.5b
BSL Raffles Medical Group	26.1x	12.6%	S$1.6b
A50 Thomson Medical Group	80.5x	14.4%	S$1.2b
5G3 TalkMed Group	21.1x	n/a	S$597.4m
STG Sri Trang Gloves (Thailand)	78.1x	50.3%	S$30.9b

Price-To-Earnings vs Peers: STG is expensive based on its Price-To-Earnings Ratio (78.1x) compared to the peer average (36.4x).

Price to Earnings Ratio vs Industry

How does STG's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?

3 Companies	Price / Earnings	Estimated Growth	Market Cap

3 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: STG is expensive based on its Price-To-Earnings Ratio (78.1x) compared to the Asian Medical Equipment industry average (25.9x).

Price to Earnings Ratio vs Fair Ratio

What is STG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

STG PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	78.1x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate STG's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

IHH Healthcare Berhad

RM 63.7b

An investment holding company, provides healthcare services in Malaysia, Singapore, Turkey, India, China, Japan, Turkey, Europe, and internationally.

Q0F

RM 2.17

0.5%

29.2%

Yunnan Energy International

HK$190.1m

An investment holding company, distributes analytical and laboratory instruments, and life science equipment in the People’s Republic of China, Hong Kong, Macau, Oceania, Asia, and internationally.

T43

HK$0.049

-34.7%

n/a

Econ Healthcare (Asia)

S$57.2m

An investment holding company, engages in the operation of medicare centers and nursing homes for eldercare in Singapore, Malaysia, and China.

EHG

S$0.21

4.9%